Targeted Therapy for LIMD1-Deficient Non-Small Cell Lung Cancer Subtypes

By
Justin.choi
-
0
78
Scientists performed the first drug repurposing screen to identify compounds that confer synthetic lethality with LIM domains containing 1 (LIMD1) loss in NSCLC cells.
[Cell Death & Disease]

Sorry, but the selected Zotpress account can't be found.

Full Article